Երկիր: Միացյալ Թագավորություն
Լեզու: անգլերեն
Աղբյուրը: VMD (Veterinary Medicines Directorate)
Chorionic Gonadotrophin
MSD Animal Health UK Limited
QG03GA01
Chorionic Gonadotrophin
Powder and solvent for solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cattle, Dogs, Horses
Hormone sex
Authorized
1994-05-18
Revised: April 2021 AN: 02063/2020 Page 1 of 6 SUMMARY OF PROUDCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Chorulon 1500 iu, powder and solvent for solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial of active contains: _Active substance:_ Chorionic gonadotrophin 1500 iu Each vial of solvent contains 5 ml of a sterile buffered solvent for reconstitution. For full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Powder and solvent for solution for injection White powder and clear colourless solution. Reconstituted solution is colourless. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, horses and dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The product can be used in the following fertility problems in domestic animals: - cases of repeated failure of conception in cows and heifers - induction of ovulation in mares and bitches - cases of cystic ovaries in cows and heifers - anoestrus in mares and bitches - delayed ovulation, prolonged pro-oestrus in bitches - deficiency in libido in male dogs 4.3 CONTRA-INDICATIONS None 4.4 SPECIAL WARNING FOR EACH TARGET SPECIES None Revised: April 2021 AN: 02063/2020 Page 2 of 6 4.5 SPECIAL PRECAUTIONS FOR USE (i) Special precautions for use in animals None (ii) Special precautions to be taken by the person administering the medicinal product to the animals Care should be taken to avoid accidental self-injection; if accidental self- injection occurs, seek medical advice immediately and show the doctor this label. Wash hands after use. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) In rare cases, as with all protein preparations, anaphylactoid incidents may occur shortly after injection. Adrenalin injection (1:1,000) given intravenously or intramuscularly when symptoms appear is the standard treatment. The administration of corticosteroids may also be indicated. 4.7 USE DURING PREGNANCY OR LACTATION Not applicable 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None 4.9 AMOUNTS T Կարդացեք ամբողջական փաստաթուղթը